Concerned about the extreme weather disasters we have had and those predicted, I reached out to Carol Atkinson, Director of Insulin for Life, a trusted organization, to see how we could help. She was so busy putting packages together for people who have diabetes, she quickly told me the story of Wharton, Texas. It was Labor Day weekend. Hurricane Harvey had just hit and it hit Wharton, Texas hard. They were in need of insulin.
Read More »Monthly Archives: September 2017
Sood & Messer Part 5, Methodology of Diabetic Treatment
Drs. Sood and Meeser talk with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas about the treatment methods that have brought them the most success for their patients.
Read More »Albuminuria: A Lot More Than Just a Little Protein in the Urine Part 5
In this week's Homerun Slides, health conditions potentially indicated by albuminuria levels.
Read More »International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #91: Lipid and Lipoprotein Metabolism, Hypolipidemic Agents, and Therapeutic Goals Part 3
In the fasting state, hepatic VLDL assembly and secretion predominate. Utilization of nascent apo B100 for the assembly and secretion of VLDL is, to a large extent, limited by substrate availability, namely TG, as apo B100 is constitutively synthesized. In the presence of adequate TG, apo B100 is progressively lipidated through the actions of hepatic MTP, and the newly assembled VLDL particle is transported to the Golgi apparatus, where it may undergo further lipidation before secretion into plasma.
Read More »Sept. 16, 2017
There always seems to be a resistance to using newer drugs in combination. Prescribers have never had a problem using metformin in combination with almost any other diabetes medication. Often you will see metformin, basal insulin, and a new drug used, but there has not been a lot of mixing …
Read More »EASD: SGLT-2/GLP-1 Combo Better Than Monotherapy
Trial finds improvement in control and weight loss.
Read More »EASD: First Oral Drug for Type 1 Diabetes – Tandem3 Study – Sotagliflozin
Addition to insulin therapy helped reduce hemoglobin A1c levels, researchers reported.
Read More »EASD: TOSCA IT Study: Older Diabetes Drugs Compared
With fewer side effects, much less expensive drugs still found to be effective.
Read More »Diabetes Management in Children Engaging In Physical Activity
Children with diabetes are often sidelined during team sports and planned exercise.
Read More »Position Statement by the American Diabetes Association: Diabetes and Hypertension
Updated blood pressure control numbers may have cardiovascular benefits for some patients.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.